Company: PFSA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001013762-25-004396
Chunk: 383

Company: Profusa, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 1B
Chunk 383
---
0.0001 par value; 1,000,000 shares authorized; none issued and outstanding 
     —  
     — 
  
    Common stock, $0.0001 par value; 100,000,000 shares authorized; 5,193,750 shares issued and outstanding at December 31, 2024 and 2023 (excluding 687,519 and 833,469 shares subject to possible redemption at December 31, 2024 and 2023, respectively) 
     519  
     519 
  
    Accumulated deficit 
     (12,957,266) 
     (3,459,829)
  
    Total Stockholders’ Deficit 
     (12,956,747) 
     (3,459,310)
  
    Total Liabilities, Redeemable Common Stock and Stockholders’ Deficit 
    $8,391,697  
    $10,884,675 

(1)In
connection with the special meeting of stockholders to vote on extending the Combination Period, on December 21, 2023, 140,663 shares
of the Company’s common stock were redeemed at a per share price of $11.13. In January 2024, $1,565,078 was paid from the Trust
Account to redeeming stockholders in connection with the extension. As a result, the Company has recorded a liability of $1,565,078 as
common stock to be redeemed and reduced common stock subject to possible redemption as of December 31, 2023 on the consolidated balance
sheet.

The
accompanying notes are an integral part of the consolidated financial statements

F-3

NORTHVIEW
ACQUISITION CORPORATION

CONSOLIDATED
STATEMENTS OF OPERATIONS

    For the Year Ended December 31, 

    2024  
    2023 
  
    Formation and operating costs 
    $1,351,038  
    $1,508,683 
  
    Loss from operations 
     (1,351,038) 
     (1,508,683)

    Other income (expense): 

    Interest income earned on investments held in trust account 
     425,416  
     2,248,538 
  
    Change in fair value of convertible note 
     (7,165,953) 
     177